147 related articles for article (PubMed ID: 11939588)
1. Molecular markers that identify human astrocytomas and oligodendrogliomas.
Popko B; Pearl DK; Walker DM; Comas TC; Baerwald KD; Burger PC; Scheithauer BW; Yates AJ
J Neuropathol Exp Neurol; 2002 Apr; 61(4):329-38. PubMed ID: 11939588
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. Nogo-A expression in oligodendroglial tumors.
Jung TY; Jung S; Lee KH; Cao VT; Jin SG; Moon KS; Kim IY; Kang SS; Kim HS; Lee MC
Neuropathology; 2011 Feb; 31(1):11-9. PubMed ID: 20487307
[TBL] [Abstract][Full Text] [Related]
4. Glycolipid markers of astrocytomas and oligodendrogliomas.
Yates AJ; Comas T; Scheithauer BW; Burger PC; Pearl DK
J Neuropathol Exp Neurol; 1999 Dec; 58(12):1250-62. PubMed ID: 10604750
[TBL] [Abstract][Full Text] [Related]
5. Expression of the genes encoding myelin basic protein and proteolipid protein in human malignant gliomas.
Golfinos JG; Norman SA; Coons SW; Norman RA; Ballecer C; Scheck AC
Clin Cancer Res; 1997 May; 3(5):799-804. PubMed ID: 9815752
[TBL] [Abstract][Full Text] [Related]
6. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
7. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.
Zhuang Z; Qi M; Li J; Okamoto H; Xu DS; Iyer RR; Lu J; Yang C; Weil RJ; Vortmeyer A; Lonser RR
J Neurosurg; 2011 Oct; 115(4):789-95. PubMed ID: 21682567
[TBL] [Abstract][Full Text] [Related]
9. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
10. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
[TBL] [Abstract][Full Text] [Related]
11. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
12. Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype.
Xu X; Joh HD; Pin S; Schiller NI; Prange C; Burger PC; Schiller MR
Cancer Lett; 2001 Sep; 171(1):67-77. PubMed ID: 11485829
[TBL] [Abstract][Full Text] [Related]
13. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
14. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
15. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.
Riemenschneider MJ; Koy TH; Reifenberger G
Acta Neuropathol; 2004 Mar; 107(3):277-82. PubMed ID: 14730454
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
17. Pathology and molecular genetics of oligodendroglial tumors.
Hartmann C; Mueller W; von Deimling A
J Mol Med (Berl); 2004 Oct; 82(10):638-55. PubMed ID: 15322700
[TBL] [Abstract][Full Text] [Related]
18. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
[TBL] [Abstract][Full Text] [Related]
19. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.
Karjalainen SL; Haapasalo HK; Aspatwar A; Barker H; Parkkila S; Haapasalo JA
BMC Cancer; 2018 May; 18(1):584. PubMed ID: 29792187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]